Per Kogner Selected Research

Irinotecan (Camptosar)

2/2007	Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo.
5/2006	Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stress.
10/2004	Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Per Kogner Research Topics

Disease

100	Neuroblastoma 02/2024 - 02/2002
80	Neoplasms (Cancer) 04/2024 - 02/2002
9	Medulloblastoma 04/2022 - 10/2008
5	Inflammation (Inflammations) 06/2018 - 01/2012
4	Brain Neoplasms (Brain Tumor) 01/2023 - 02/2002
3	Lung Neoplasms (Lung Cancer) 01/2023 - 11/2009
3	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 02/2017
3	Carcinogenesis 01/2016 - 12/2008
3	Pheochromocytoma 04/2014 - 06/2005
3	Residual Neoplasm 11/2011 - 04/2003
3	Ganglioneuroma 01/2007 - 02/2002
2	Lymphoma (Lymphomas) 01/2019 - 02/2015
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2018 - 06/2005
2	Teratoma (Teratoid Tumor) 01/2018 - 04/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 11/2009
2	Infections 01/2017 - 07/2010
2	Chromosome Aberrations (Chromosome Abnormalities) 03/2016 - 01/2012

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2004
13	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2003
11	Messenger RNA (mRNA)IBA 01/2022 - 01/2003
9	Dinoprostone (PGE2)FDA Link 01/2023 - 10/2008
8	Anaplastic Lymphoma KinaseIBA 01/2022 - 12/2008
7	RNA (Ribonucleic Acid)IBA 02/2024 - 10/2011
7	Prostaglandin-E SynthasesIBA 01/2023 - 10/2008
6	Phosphotransferases (Kinase)IBA 01/2022 - 01/2010
6	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2008
6	LigandsIBA 01/2020 - 02/2002
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 05/2006
5	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 10/2004
5	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2006 - 10/2004
4	Long Noncoding RNAIBA 01/2024 - 11/2014
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 04/2022 - 05/2006
4	Protein Isoforms (Isoforms)IBA 03/2021 - 11/2010
4	RetinoidsIBA 01/2017 - 04/2003
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2017 - 04/2003
4	EnzymesIBA 06/2015 - 02/2007
4	Diclofenac (SR 38)FDA LinkGeneric 06/2015 - 10/2004
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2012 - 10/2004
4	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2012 - 10/2004
4	Celecoxib (Celebrex)FDA Link 10/2011 - 10/2004
4	Peptides (Polypeptides)IBA 01/2006 - 02/2002
4	Protons (Proton)IBA 10/2005 - 10/2004
4	Choline (Choline Chloride)IBA 10/2005 - 10/2004
3	venetoclaxIBA 01/2024 - 01/2016
3	MicroRNAs (MicroRNA)IBA 01/2023 - 07/2011
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2021 - 03/2013
3	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 07/2010
3	rho-Associated KinasesIBA 12/2019 - 03/2016
3	CalciumIBA 11/2017 - 01/2012
3	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 10/2004
3	LipidsIBA 06/2015 - 10/2005
3	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2013 - 03/2013
3	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2013 - 01/2010
3	ProstaglandinsIBA 01/2012 - 10/2008
3	Prostaglandins EIBA 01/2012 - 10/2008
3	Docosahexaenoic AcidsIBA 04/2011 - 05/2006
3	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 12/2008 - 01/2003
3	Arachidonic Acid (Vitamin F)IBA 10/2008 - 10/2004
3	Irinotecan (Camptosar)FDA LinkGeneric 02/2007 - 10/2004
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2006 - 10/2005
3	GalaninIBA 01/2006 - 02/2002
3	Galanin Receptors (Galanin Receptor)IBA 01/2006 - 02/2002
2	Drug CombinationsIBA 04/2024 - 07/2023
2	nutlin 3IBA 01/2022 - 11/2021
2	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 11/2015
2	RadiopharmaceuticalsIBA 01/2022 - 01/2007
2	NSC 652287IBA 09/2021 - 09/2013
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2020 - 10/2008
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019 - 12/2008
2	Genetic Markers (Genetic Marker)IBA 03/2018 - 08/2009
2	CytokinesIBA 11/2017 - 03/2013
2	ChemokinesIBA 11/2017 - 01/2016
2	Cytostatic AgentsIBA 02/2017 - 12/2004
2	Aurora KinasesIBA 01/2017 - 09/2013
2	Melphalan (Alkeran)FDA LinkGeneric 01/2017 - 09/2007
2	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 07/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 07/2010
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 11/2014
2	Differentiation AntigensIBA 01/2017 - 03/2009
2	CateninsIBA 03/2016 - 11/2015
2	Complementary DNA (cDNA)IBA 03/2016 - 01/2016
2	Macrophage Colony-Stimulating FactorIBA 01/2016 - 01/2016
2	4- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamideIBA 01/2016 - 01/2016
2	MethyltransferasesIBA 11/2015 - 12/2004
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 06/2015 - 03/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2014 - 08/2009
2	Thromboxane A2 (A2, Thromboxane)IBA 07/2013 - 05/2013
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2013 - 05/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2011 - 08/2009
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 04/2011 - 03/2010
2	trichostatin A (A 300)IBA 02/2011 - 07/2008

Therapy/Procedure

32	Therapeutics 01/2022 - 03/2003
12	Drug Therapy (Chemotherapy) 02/2024 - 10/2004
4	Immunotherapy 11/2018 - 11/2003
3	Radiotherapy 01/2022 - 05/2017
2	Precision Medicine 01/2023 - 03/2016
2	Transplantation 01/2018 - 04/2014
2	Combined Modality Therapy 01/2016 - 05/2013
2	Heterologous Transplantation (Xenotransplantation) 01/2016 - 04/2014
2	Injections 03/2014 - 08/2006